Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes

Página do item simplificado
dc.creatorIacobellis, Gianluca
dc.creatorPenaherrera, Carlos A.
dc.creatorBermudez, Luis E.
dc.creatorBernal Mizrachi, Ernesto
dc.date.accessioned2020-05-09T00:45:54Z
dc.date.available2020-05-09T00:45:54Z
dc.date.issued2020
dc.description.abstractDiabetes emerged as major risk factor for severe acute respiratory syndrome (SARS) and adverse outcome in patients with the coronavirus disease 2019 (COVID-19). Nevertheless, the role of admission hyperglycemia in patients with COVID-19 has not been well-explored, yet. With this retrospective analysis, we report for the first time that hyperglycemia on day-1 is the best predictor of radiographic imaging of SARS-CoV2, regardless of the past medical history of diabetes. Admission hyperglycemia should not be overlooked, but adequately treated to improve the outcomes of COVID-19 patients with our without diabetes.pt_BR
dc.identifier.citationIACOBELLIS, G. et al. Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes. Diabetes Research and Clinical Practice, [S.l.], v. 164, 2020.pt_BR
dc.identifier.urihttps://repositorio.ufla.br/handle/1/40752
dc.identifier.urihttp://www.sciencedirect.com/science/article/pii/S0168822720304356pt_BR
dc.languageen_USpt_BR
dc.publisherElsevierpt_BR
dc.rightsopenAccesspt_BR
dc.sourceDiabetes Research and Clinical Practicept_BR
dc.subjectCOVID-19pt_BR
dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)pt_BR
dc.subjectHyperglycemiapt_BR
dc.subjectDiabetespt_BR
dc.titleAdmission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetespt_BR
dc.typeArtigopt_BR

Arquivos

Licença do pacote

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
license.txt
Tamanho:
953 B
Formato:
Item-specific license agreed upon to submission
Descrição:
Baixar

Coleções

FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)